Clinical Trial Update: Acthar as Rescue Therapy for Transplant Glomerulopathy in Kidney Transplant Recipients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on Acthar as rescue therapy for transplant glomerulopathy in kidney transplant recipients; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Proteinuria
• Transplant Glomerulopathy

Drugs mentioned

• Acthar (repository corticotropin injection)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Proteinuria, Transplant Glomerulopathy | Phase 4 | Status: TERMINATED | Results posted: 2020-09-04